DISCOUNT-OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 20:45:25 24/05/2024 BST | ||
| 0.95 EUR | -1.04% |
|
| Current month | +206.45% | ||
| 1 month | +227.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 0.95 | -1.04% |
| 23/05/24 | 0.96 | -20.66% |
| 22/05/24 | 1.21 | -15.97% |
| 21/05/24 | 1.44 | +8.27% |
| 20/05/24 | 1.33 | +1.53% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 08:45 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC8K4E |
| ISIN | DE000HC8K4E9 |
| Date issued | 10/08/2023 |
| Strike | 300 $ |
| Maturity | 19/06/2024 (24 Days) |
| Parity | 10 : 1 |
| Emission price | 0.6 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.59 € |
|---|---|
| Lowest since issue | 0.2 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
